2016
DOI: 10.2147/iprp.s83261
|View full text |Cite
|
Sign up to set email alerts
|

Community pharmacy: an untapped patient data resource

Abstract: As community pharmacy services become more patient centered, they will be increasingly reliant on access to good quality patient information. This review describes how the information that is currently available in community pharmacies can be used to enhance service delivery and patient care. With integration of community pharmacy and medical practice records on the horizon, the opportunities this will provide are also considered. The community pharmacy held patient medication record, which is the central info… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
19
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(19 citation statements)
references
References 36 publications
0
19
0
Order By: Relevance
“…Medication data can be used in research to assess changes in medication prescribing trends over time [ 1 ], for pharmacovigilance studies, and to investigate patients not adhering to the treatment plans agreed upon with their General Practitioner (GP) [ 2 – 4 ]. Investigating medication data enables researchers to estimate the frequency, burden, and costs of non-adherence [ 5 7 ], identify the most at-risk to suboptimal clinical outcomes, evaluate the effectiveness of adherence interventions [ 8 – 10 ], and appropriately adjust for the impact of non-adherence on safety and efficacy data in clinical trials [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Medication data can be used in research to assess changes in medication prescribing trends over time [ 1 ], for pharmacovigilance studies, and to investigate patients not adhering to the treatment plans agreed upon with their General Practitioner (GP) [ 2 – 4 ]. Investigating medication data enables researchers to estimate the frequency, burden, and costs of non-adherence [ 5 7 ], identify the most at-risk to suboptimal clinical outcomes, evaluate the effectiveness of adherence interventions [ 8 – 10 ], and appropriately adjust for the impact of non-adherence on safety and efficacy data in clinical trials [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…While analysis of medication adherence can be estimated using either the GP’s prescribing records or the NHSBSA medication dispensing records alone, there are limitations to each approach. Without linking the records together, it is not possible to ascertain whether a prescribed medication was collected, or to rule out other reasons for irregularities in collection such as treatment conclusion or sanctioned treatment interruptions [ 1 , 23 , 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…With rising prescription medication use, polypharmacy, and patients receiving care from numerous providers [11,12], there is a distinct need for the expertise of a pharmacist to help manage medication-related fall risk. Due to their access to patients and medication records [13], community pharmacists are ideally positioned to partner with providers, payers, and public health stakeholders to reduce the risk of falls through screening, medication management, and referral.…”
Section: Introductionmentioning
confidence: 99%
“…It has been recommended that pharmacists document any professional activities that are intended to ensure the safe and effective use of drugs and that may affect patient outcomes [7]. However, documentation of clinical activities still remains a challenge [6], particularly in community pharmacies [8].…”
Section: Introductionmentioning
confidence: 99%